American cannabis technology will now be available in Europe thanks to a new transatlantic deal.
The deal is between liquid cannabis company ALT (Advanced Liquid Technology) and European distributor Grow Group. The distributor will market and supply their liquid medical cannabis across the continent.
ALT pride themselves on producing cannabis liquids that are unique and kinetically stable, which according to a statement, allows for “more effective delivery of cannabinoids to the user.”
They claim that patients “benefit from the rapid onset of effects within 5-15 minutes” and it “enables doctors to recommend precise doses of cannabinoids to patients based on their individual need”.
ALT’s CEO, Robert Davis, discussed the development of this partnership with Grow Group. He said: “We are honored to partner with Grow in bringing ALT’s completely differentiated brand and liquid medical cannabis technologies to the European medical markets.”
Mr Davis also mentioned that this expansion is in addition to a recent launch in California. He added: “After successfully launching ALT into California in December of 2020, we are excited to expand internationally, our first step in becoming a global brand. ALT’s mission is to Enhance Human Potential and we will do so, one patient at a time, through the power of our liquid cannabis platform.”
It is expected that ALT will have a range of EU GMP-certified liquid cannabis products available in both the UK and Germany by early next year. The ALT liquid has zero-calories, is sugar-free, and vegan and keto friendly
